NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Nalu Medical

Nalu Medical

Private
Carlsbad, CaliforniaHealthcare & Life Scienceshttps://www.nalumed.com

Last Round

Series E

Extension

Mar 5, 2024

Total Funding Raised

$310.9M

Company Overview

Nalu Medical is a medical device company specializing in neuro-stimulation solutions that alleviate chronic pain through innovative, battery-free, micro-implantable pulse generators for spinal cord and peripheral nerve stimulation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurostimulation systemchronic pain treatmentneurostimulatorSpinal Cord StimulationSCSPeripheral Nerve StimulationPNSimplantable pulse generatorIPGneuromodulationpain managementbattery-free implantminimally invasive devicepain techwearable power sourcemedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nalu Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nalu Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series E ExtensionMar 5, 2024
Series EDec 21, 2023
DebtOct 20, 2022
Series BFeb 17, 2022
Series CJul 1, 2020
Series A
Jul 8, 2015

Key People

Founding team and executive leadership

Thomas A. West

President, CEO And Director

Executive Team

Prabodh Mathur

Chief Technology Officer

Executive Team

Jeff Swiecki

Chief Financial Officer

Executive Team

Nalu Medical Investors

Notable investors and investment history

InvestorRounds
Longitude CapitalSeries B, Series C, Series E, Series E Extension
Runway Growth CapitalDebt
B Capital GroupSeries E
Advent Life SciencesSeries B, Series C, Series E, Series E Extension
Gilde HealthcareSeries E, Series E Extension, Series B
Novo HoldingsSeries E Extension, Series E
Endeavour VisionSeries B, Series C, Series E, Series E Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2025

    Launched a smaller wearable device for chronic pain therapy.

  • Apr 3, 2025

    Raymond W. Cohen appointed as new chairman of the board.

Nalu Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nalu Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nalu Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlsbad, California
Employee Range257
Year Founded2014
Last FundingMar 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.